Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Medicine, Ophthalmology, Ranibizumab, Aflibercept, Macular edema, and Central retinal vein occlusion.
A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration—the FALCON study
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study
Selective retina therapy: toward an optically controlled automatic dosing
Optical coherence tomography angiography analysis of macular flow density in glaucoma
Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B)
Integrated results from the COPERNICUS and GALILEO studies
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol
Vitrectomy with and without encircling band for pseudophakic retinal detachment: VIPER Study Report No 2—main results
The German ROP Registry: data from 90 infants treated for retinopathy of prematurity
The German ROP Registry: Association of demographic factors and the requirement for re-treatments of retinopathy of prematurity
Investigative Ophthalmology & Visual Science 2016cited by 0position: middle
Cardiovascular Risk Factors in Central Retinal Artery Occlusion
Increased Expression of Angiogenic and Inflammatory Proteins in the Vitreous of Patients with Ischemic Central Retinal Vein Occlusion
Correlation Between Hyperreflective Foci and Clinical Outcomes in Neovascular Age-Related Macular Degeneration After Switching to Aflibercept
Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (<scp>RABAMES</scp>): six‐month results of a prospective randomized clinical trial
Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review